αB-crystallin expression is correlated with phospho-ERK1/2 expression in human breast cancer

Chantal van de Schootbrugge, Freekje van Asten, Iris D. Nagtegaal, Yvonne M. Versleijen-Jonkers, Hanneke W. M. van Laarhoven, Melissa H. Roeffen, Fred C. G. J. Sweep, Johan Bussink, Johannes H. A. M. Kaanders, Ger J. M. Pruijn, Wilbert C. Boelens, Paul N. Span

Research output: Contribution to JournalArticleAcademicpeer-review

4 Citations (Scopus)

Abstract

αB-crystallin is regarded as a biomarker for triple-negative and/or basal-like breast cancer. In normal breast cells, overexpression of αB-crystallin leads to neoplastic-like changes, which likely relate to enhanced expression of phosphorylated ERK1/2 (pERK1/2). In this study, we investigated whether αB-crystallin expression is correlated to pERK1/2 expression in breast cancer. In a balanced tissue microarray the expression of αB-crystallin and pERK1/2 kinase were determined immunohistochemically, together with the triple-negativity and basal-like markers CK5/6 and SMA and the signaling molecules pAKT, pmTOR, EGFR, and IGF-1R. αB-crystallin expression significantly correlated with triple negativity and basal-like markers CK5/6 and SMA (Pearson Chi-square test p=0.004, p=0.001, and p <0.001, respectively). A significant correlation was also observed with pERK1/2 expression (p=0.002). siRNA-mediated knockdown of αB-crystallin in the triple-negative breast cell line MDA-MB468 did not show an effect on pERK1/2 expression levels, indicating that lowering the level of αB-crystallin does not reduce pERK1/2 expression. Our results confirm that αB-crystallin can be used as a biomarker for triple-negative and/or basal-like breast cancer. The expression of αB-crystallin correlates with pERK1/2 expression in breast cancer tissue suggesting that therapies targeting αB-crystallin might be considered for treatment of triple-negative or basal-like breast cancer
Original languageEnglish
Pages (from-to)e365-e370
JournalInternational journal of biological markers
Volume28
Issue number4
DOIs
Publication statusPublished - 2013

Cite this